BJL
WST icon

Brighton Jones LLC’s West Pharmaceutical WST Stock Holding History

Brighton Jones LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,514
Closed -$660K – 980
2025
Q3 		$660K Buy
+2,514
New +$611K 0.02% 531

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brighton Jones LLC's WST Position: Q4 2025 in Review

Brighton Jones LLC sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 2,514 shares — an estimated $660K sold.

Brighton Jones LLC first reported a position in WST in Q3 2025 and held it in 1 quarter. The position peaked at $660K in Q3 2025. 803 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Brighton Jones LLC reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Brighton Jones LLC sold 2,514 West Pharmaceutical shares in Q4 2025, an estimated $660K.
  • Brighton Jones LLC first reported a position in West Pharmaceutical in Q3 2025 and held it in 1 quarter.
  • Brighton Jones LLC's West Pharmaceutical position peaked at $660K in Q3 2025.
  • 803 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Brighton Jones LLC's 13F filing for Q4 2025, filed 27 Jan 2026.